Gambia vs Mauritania: Population requiring preventive chemotherapy for schistosomiasis
Gambia
657,160
in 2024
Mauritania
596,151
in 2024
Gambia rank
37th
Mauritania rank
38th
Population requiring preventive chemotherapy for schistosomiasis over time
- Gambia
- Mauritania
How they compare
Gambia currently reports 657,160 against 596,151 in Mauritania, a difference of 61,009.
That makes Gambia's figure about 1.1 times Mauritania's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Mauritania ahead.
Gambia ranks 37th and Mauritania ranks 38th of 52 countries.
Mauritania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 158,622 | 706,396 | 547,775 | Mauritania |
| 2020s | 439,450 | 849,983 | 410,533 | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Gambia or Mauritania?
- Gambia, at 657,160 against 596,151 in Mauritania as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Gambia and Mauritania?
- 61,009, with Gambia ahead.
- How many years of comparable data are there for Gambia and Mauritania?
- 15 years are reported by both, from 2010 to 2024.
- How do Gambia and Mauritania rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Gambia ranks 37th and Mauritania ranks 38th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.